Confirmed Expert Practitioners Speaking at Developing IP Strategies for Crystalline Forms 2010

Maximising Crystalline Form Patent Wealth through Effective Patenting, Litigation and Lifecycle Extension

‘In less than 24 months, 26 blockbuster medicines, worth over $69 billion or thrice the size of the domestic industry — are going off-patent…’ April 27, 2010, Joe C Mathew, Business Standard

As an increasing number of blockbuster patents expire and R&D piplelines shrink, it is becoming increasingly important to have a successful application and litigation strategy to protect and maximise the revenue from existing patents. A substantial proportion of pharmaceutical products are crystalline forms which, due to the intricacies of obviousness and novelty, are notoriously difficult to patent and litigate. In light of this, Pharma IQ’s Developing IP Strategies for Crystalline Forms conference will bring together leading professionals working within in house counsel, patent offices, law firms and Judiciary to explore the challenges, trends and successful approaches employed and in turn, help you to maximise return from crystalline patents.

Industry practitioners from around the world will share their expertise to help you:

Event History & Profile

  • Now in its 6th year, run by a team with over 25 years of event experience
  • Over 700 hours of programme development go into each event
  • Approximately 100 thought leaders and industry trailblazers contribute to the formation of the conference
  • Over 150 hours of conversations with the marketplace happen whilst the agenda is being shaped
  • 16+ top flight speakers and panellists join the faculty to share their wisdom and knowledge

TESTIMONIALS

Very valuable as I'm coming from science
Dr Michael Becker, Solvias AG
Good speakers with vast subject knowledge & contributing
Dr Mandar Kodgule, Wockhardt Ltd
Great!
Dr Rajeev Rehani, Sun Pharmaceutical Ind. Ltd
Media Partners
MPs